Top Healthcare Stocks
Healthcare stocks are narrowly higher, with the NYSE Healthcare
Sector Index climbing 0.3% while shares of healthcare companies in
the S&P 500 are holding a 0.2% gain as a group.
In company news, Agenus Inc. (
) shares are up more than 20% at $2.94 apiece, reaching some of
their best levels since early September at $3.20 apiece after the
biotech reported positive results from Phase II testing of its
Prophage Series G-200 brain-cancer vaccine treatment.
According to the company, 90% of patients with surgically
resectable recurrent high-grade glioblastoma multiform - the
deadliest form of brain cancer - treated with Prophage were alive
six months after receiving the drug, meeting the primary objective
of the multi-center, single arm trial.
Approximately 30% of the trial patients were alive at twelve
months, with a median overall survival of around eleven months.
In other sector news,
(+) CBST, (+7.2%) Its ceftolozane/tazobactam antibiotic
candidate combined with metronidazole met primary endpoints of
statistical non-inferiority compared to meropenem in Phase III
testing in patients with complicated intra-abdominal
(-) PIP, (-2.0%) FDA places a clinical hold on the company's
SparVax rPA anthrax vaccine program. Phase II trials had been
expected to begin before year's end; a letter explaining the
agency's reasons are expected within 30 days.